Acinetobacter baumannii-calcoaceticus complex infection (ABC)
Clinical trials for Acinetobacter baumannii-calcoaceticus complex infection (ABC) explained in plain language.
Never miss a new study
Get alerted when new Acinetobacter baumannii-calcoaceticus complex infection (ABC) trials appear
Sign up with your email to follow new studies for Acinetobacter baumannii-calcoaceticus complex infection (ABC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibiotic under safety watch for hospital superbug
Disease control Recruiting nowThis study is checking how safe the antibiotic sulbactam-durlobactam is for people hospitalized with a hard-to-treat bacterial infection called Acinetobacter baumannii. Researchers will watch 100 participants for about 28 days to see if they have any side effects, especially alle…
Matched conditions: ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX INFECTION (ABC)
Sponsor: Innoviva Specialty Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New antibiotic combo tested in kids to fight superbug infections
Disease control Recruiting nowThis study is testing an antibiotic called Sulbactam-Durlobactam in hospitalized children from birth to under 18 years old who have or may have an Acinetobacter infection. The goal is to find the right dose and check that it is safe. About 48 children will receive the drug throug…
Matched conditions: ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX INFECTION (ABC)
Phase 1 • Sponsor: Innoviva Specialty Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC